← Back to Search

Group-Based Community Reinforcement Approach and Family Training-Early Psychosis Intervention (CRAFT-EPI) for Substance Use Disorder (CRAFT-EPI Trial)

N/A
Waitlist Available
Led By Nicole Kozloff, MD, SM
Research Sponsored by Centre for Addiction and Mental Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks, 18 weeks
Awards & highlights

CRAFT-EPI Trial Summary

This trial is testing whether a new intervention called CRAFT-EPI can help people with early psychosis and their concerned loved ones. The intervention is given in a group setting, and includes measures to assess feasibility for a larger trial.

Eligible Conditions
  • Substance Use Disorder
  • Substance Abuse
  • Schizophrenia
  • Psychosis

CRAFT-EPI Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of treatment entry for substance use
Rates of assessment completion
Rates of recruitment
+1 more
Secondary outcome measures
Contemplation Ladder total score
Generalized Anxiety Disorder-7 (GAD-7) total score
Happiness Scale total score
+4 more

CRAFT-EPI Trial Design

1Treatment groups
Experimental Treatment
Group I: Intervention armExperimental Treatment1 Intervention
Family member/concerned significant other
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Group-Based Community Reinforcement Approach and Family Training-Early Psychosis Intervention (CRAFT-EPI)
2022
N/A
~20

Find a Location

Who is running the clinical trial?

Centre for Addiction and Mental HealthLead Sponsor
356 Previous Clinical Trials
81,430 Total Patients Enrolled
Mclean HospitalOTHER
213 Previous Clinical Trials
21,680 Total Patients Enrolled
Nicole Kozloff, MD, SMPrincipal InvestigatorCentre for Addiction and Mental Health
1 Previous Clinical Trials
186 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities to participate in the research currently available?

"Data from clinicaltrials.gov indicates that this medical trial is no longer in need of volunteers, the post first appearing on February 8th 2022 and being updated most recently on March 28th 2022. However, there are still 1703 other biomedical research studies enrolling right now."

Answered by AI

What are the key objectives of this trial?

"As participants go through the 18 week trial, their retention rate will be monitored as its primary outcome. Additionally, investigators are evaluating measures of anxiety (GAD-7 score), stress levels (PSS-14 item total score) and symptoms of depression (PHQ-9 total score)."

Answered by AI
~4 spots leftby Apr 2025